These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20713344)

  • 21. Cervical thyroid remnant consistent with papillary carcinoma as an incidental finding in a patient with benign total thyroidectomy ten years prior.
    Ruano Campos A; Rivera Alonso D; Ochagavía Cámara S
    Pol Przegl Chir; 2019 Jul; 92(1):52-54. PubMed ID: 32312925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False-positive radioiodine uptake in a functional ovarian cyst in a patient treated with total thyroidectomy for papillary cancer.
    Jang HY; Kim BH; Kim WJ; Jeon YK; Kim SS; Kim YK; Kim IJ
    Intern Med; 2013; 52(20):2321-3. PubMed ID: 24126393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.
    Taylor T; Specker B; Robbins J; Sperling M; Ho M; Ain K; Bigos ST; Brierley J; Cooper D; Haugen B; Hay I; Hertzberg V; Klein I; Klein H; Ladenson P; Nishiyama R; Ross D; Sherman S; Maxon HR
    Ann Intern Med; 1998 Oct; 129(8):622-7. PubMed ID: 9786809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unresectable huge sternal and mediastinal metastasis of follicular thyroid carcinoma; radiotherapy as first-line and palliative therapy.
    Nar Demirer A; Ayturk S; Tutuncu NB; Gursoy A; Pak Y; Demirag NG
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):155-8. PubMed ID: 18561094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
    Lee JI; Chung YJ; Park SJ; Ryu HS; Cho BY
    Thyroid; 2012 Oct; 22(10):1084-7. PubMed ID: 22873179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
    Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
    Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
    Rosario PW
    Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma.
    Wang SF; Zhao WH; Wang WB; Teng XD; Teng LS; Ma ZM
    Asian Pac J Cancer Prev; 2013; 14(2):707-11. PubMed ID: 23621223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iodine concentration by the thymus in thyroid carcinoma.
    Vermiglio F; Baudin E; Travagli JP; Caillou B; Fragu P; Ricard M; Schlumberger M
    J Nucl Med; 1996 Nov; 37(11):1830-1. PubMed ID: 8917186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of differentiated thyroid carcinomas. Prospective study].
    Gemsenjäger E; Staub JJ; Heitz PU
    Schweiz Med Wochenschr; 1985 Feb; 115(5):153-9. PubMed ID: 3975583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment for microcarcinoma of the thyroid. Clinical experience].
    Conzo G; Esposito MG; Di Marzo M; Astarita G; Celsi S
    Tumori; 2003; 89(4 Suppl):210-1. PubMed ID: 12903596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 131I Whole-Body Scan Incidental Uptake Due to Spermatocele.
    Albano D; Motta F; Baronchelli C; Lucchini S; Bertagna F
    Clin Nucl Med; 2017 Nov; 42(11):901-904. PubMed ID: 28902733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
    Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
    Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of recombinant human thyrotropin in a complicated case of metastatic papillary thyroid carcinoma.
    Aslam SN; Daly RG
    Endocr Pract; 2001; 7(2):99-101. PubMed ID: 11421553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mediastinal images resembling thymus following 131-I treatment for thyroid cancer.
    Montella L; Caraglia M; Abbruzzese A; Soricelli A; Caputi M; Squame G; Salvatore M; Del Prete S; Palmieri G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):114-7. PubMed ID: 16128228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.